Mobility paves Samsung’s silver path
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
The company had recruited over 25,000 volunteers - AMIT DAVE
The Phase-III trials of Covaxin, the Covid-19 vaccine candidate being developed by Bharat Biotech, received a jolt as a volunteer passed away.
“We would like to state that a volunteer passed away on December 21, 2020 and the death was reported to the People’s College of Medical Sciences & Research Centre by the son of the deceased,’’ Bharat Biotech said in a statement on Saturday.
Covaxin has been granted emergency use authorisation by the Drug Controller General of India and the vaccination is set to begin shortly.
As of now, about 25,800 volunteers have been recruited by the company and Phase-III trials are under way in different locations.
The Hyderabad-based vaccine maker, however, claimed the volunteer had ‘fulfilled’ all the inclusion and exclusion criteria to be accepted as a participant in the trial and was reported to be healthy in all the site follow-up calls post-seven days of his dosing; no adverse events were observed or reported. As per the post-mortem report issued by the Gandhi Medical College, Bhopal, the probable cause of death was cardio respiratory failure as a result of suspected poisoning. The case is under police investigation.
“The volunteer passed away nine days after the dosing and preliminary reviews by the site indicate that the death is unrelated to the study dosing. We cannot confirm if the volunteer received the study vaccine or a placebo as the study is blinded,’’ the company said.
In accordance with the provisions of the New Drugs & Clinical Trials Rules, (NDCT rules 2019), the serious adverse event was reported by the site team to the Institutional Ethics Committee, the Central Drugs Control Standards Organization (CDSCO) and the Data Safety Monitoring Board (DSMB) in accordance with all the required guidelines.
“We are also continuing to cooperate with the investigation requirements of the Madhya Pradesh Police in Bhopal,’’ the vaccine-maker said.
“Our sympathies are with the family of the deceased. However, we would like to reiterate that we conduct our clinical trials in compliance with the study protocol, Good Clinical Practices (GCP) guidelines as well as with all applicable statutory provisions and the focus at all times is on patient safety,’’ Bharat Biotech said.
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
Antrix should adopt a different tactic than merely fighting over jurisdiction: Experts
Invest in relationships, enterprise, behaviour, effort and learning
From different types of osmoses to new membranes, researchers have come up with ways of drawing water
Only half the Sensex stocks have bettered the index’s return in the last 10,000-point journey
High valuation and stiff competition from larger players are a dampener
Investors with a short-term perspective can buy The New India Assurance Company (NIACL) stock at current ...
₹1490 • HDFC Bank S1S2R1R2COMMENT 1475146015051520 Fresh short positions are recommended with a stiff ...
What makes the new crop of young Indian cricketers such game-changing winners? Over and above their talent, ...
Regina King’s film ‘One Night in Miami’ turns the spotlight on four young men’s often conflicting ideas of ...
Each new year millions of people around the world resolve to change their lives for the better. These ...
In these isolated times when people yearn for a slice of the familiar, amateur and professional chefs are ...
Digital is becoming dominant media, but are companies and their ad agencies transforming fast enough to make a ...
Slow Network, promoted by journalist-lyricist Neelesh Misra, pushes rural products and experiences
How marketers can use the traditional exchange of festive wishes meaningfully
For Fortune, a brand celebrating its 20th anniversary, it was a rude shock to become the butt of social media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...